Laura Periman, MD, breaks down some myths and controversies in the cosmetic world in her presentation, "Ocular toxins everywhere and in everything," presented at the Controversies in Modern Eye Care meeting.

David S. Boyer, MD, shares highlights from the symposium on advances in the geographic atrophy space, which he presented during the 17th annual Controversies in Modern Eye Care meeting.

Leo Semes, OD, shares highlights from his presentation on early detection of AMD, which he presented during the 17th annual Controversies in Modern Eye Care.

David Liao, MD, shares highlights from his discussion on evolving treatment strategies for neovascular AMD and DME, during the 17th annual Controversies in Modern Eye Care meeting.

Neda Shamie, MD, welcomes attendees to the 17th annual Controversies in Modern Eye Care meeting, and shares sneak peeks of her two presentations throughout the day.

Welcome to the 17th annual Controversies in Modern Eye Care symposium! Cochair and presenter, Dr. Arjan Hura, shares a sneak peak of his presentation later this morning.

Welcome to the 17th annual Controversies in Modern Eye Care symposium!

Catch up on what happened in optometry during the week of April 24-April 28.

New and returning special events and features on tap at annual meeting

The study found that pseudophakic children older at the time of surgery developed a glaucoma-related adverse event less frequently.

How to fit lenses with simple devices and when to expand your armature.

In a sham device-controlled, randomized, double-blind clinical trial in China, researchers utilized a device that emits 650 nm red light directly to the retina.

The 20-20-20 rule has taken on a life of its own, but it remains a useful trick to reduce digital eye strain.

The aspheric, monofocal, single-piece C-loop IOL from Zeiss compensates for a range of spherical aberrations to minimize decentration and lens misalignments.

Pediatric glaucoma, although rare, can cause irreversible vision loss and leave children visually impaired if not treated timely and adequately.

The GA Won’t Wait campaign is designed to help older adults and their families understand and recognize the symptoms of this progressive and irreversible disease.

Deborah Ferrington, PhD, shares a brief overview of her presentation on identifying the mechanism responsible for the death of the retinal pigment epithelium.

Andrew Pucker, OD, MS, PhD, FAAO, and George Magrath, MD, discuss Lexitas Pharma Services' work on modification of the National Eye Institute's corneal fluorescein staining scale.

Mark Bullimore, PhD, MCOptom, shares a brief overview of her presentation on myopia management by slowing progression with low concentration atropine.

Several eye conditions may benefit from membrane application.